Dr. Moye is studying early-stage lung cancer. Specifically, he is investigating the cell-to-cell cross talk between lung cancer cells and their surrounding microenvironment and how this cellular communication promotes early-stage lung cancer initiation and progression. Dr. Moye aims to discover secreted factors that can be used in diagnosis and to identify new targets for drug development that interfere with the lung cancer microenvironment.
Damon Runyon Researchers
Meet Our Scientists
Aaron L. Moye, PhD
Project title: "Role of Lgr6-expressing mesenchymal cells in lung cancer initiation and progression"
Institution: Boston Children's Hospital
Award Program: Fellow
Sponsor(s) / Mentor(s): Carla F. Kim, PhD
Cancer Type: Lung
Research Area: Cancer Genetics
